Brief: Pfizer Confirms Receiving Letter From U.S. House Committee Probing China Drug Trials
Yesterday 14:13
BRIEF-Pfizer Confirms Receiving Letter From U.S. House Committee Probing China Drug Trials June 30 (Reuters) - Pfizer Inc PFE.N:
PFIZER CONFIRMS RECEIVING LETTER FROM U.S. HOUSE COMMITTEE PROBING CHINA DRUG TRIALS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Pfizer
See all newsU.S. STOCKS ON THE MOVE-Chip stocks, Unicycive, Roblox
U.S. STOCKS ON THE MOVE-AMD, Roblox, Olin
Eli Lilly, Pfizer slip after US House panel probing China clinical trials
US House committee opens investigation into Merck, AbbVie China drug trials (updated)
Brief: U.S. House Committee Sends Letters To Pfizer, Eli Lilly & Bristol Myers Squibb Probing China Drug Trials